mbiomics
Agent46Agent Readiness: 46/100. Above median. Measured by StartupHub.ai. Median 41.Trust80Data Trust: 80/100. Top 25%. Measured by StartupHub.ai. Median 61.Advancing scalable microbiome-based therapeutics for severe and chronic diseases.
About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules
About
mbiomics designs and develops complex Live Biotherapeutic Products (LBPs) to change the treatment paradigm of severe and chronic diseases. They leverage proprietary precision analytics and patient insights to build a pipeline of rationally selected microbial communities for indication-specific treatment. Their goal is to access the gut microbiome's full immunological and metabolic potential to restore healthy microbial ecosystems and overcome disease.
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Therapeutics
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Shares Biotechnology, Drug Discovery
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Shares Biotechnology, Pharmaceuticals
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- mbiomics.com
- Headquarters
- Munich, Bavaria, Germany
- Founded
- 2020
- Total funding
- $12M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Apr 2026 | Series A | $12M |
Tech stack
Detected on mbiomics.com, last scanned 2 Nov 2026. Run your own scan
- CMS / Builders
- Framer
mbiomics scores 12. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is mbiomics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for mbiomics is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has mbiomics raised?
mbiomics has raised a total of $12M in funding. The most recent round on record is Series A.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for mbiomics
